Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share (LYEL) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2021 to Q3 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
LYEL on Nasdaq
Shares outstanding
19,277,111
Price per share
$16.24
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
650,353
Total reported value
$10,561,733
% of total 13F portfolios
0%
Share change
-1,790,320
Value change
-$15,728,473
Number of holders
2
Price from insider filings
$16.24
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share (LYEL) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARCH Venture Fund IX, L.P. 13% $17,200,927 36,597,716 Robert Nelsen 31 Dec 2024
Foresite Capital Fund IV, L.P. 9.2% +36% $12,766,089 +$3,611,010 27,161,892 +39% James B. Tananbaum 31 Mar 2025
BlackRock, Inc. 4.5% $6,234,958 13,265,869 BlackRock, Inc. 31 Dec 2024
Explore Investments LLC/DE 5.4% $9,202,122 1,040,964 Explore Investments LLC 25 Jul 2025

As of 30 Sep 2025, 2 institutional investors reported holding 650,353 shares of Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share (LYEL). This represents 3.4% of the company’s total 19,277,111 outstanding shares.

Institutional Holders of Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share (LYEL) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 650,353 $10,561,733 -$15,728,473 $16.24 2
2025 Q2 2,440,673 $21,579,143 -$465,374,774 $8.84 6
2025 Q1 152,354,676 $81,758,597 +$815,972 $0.54 111
2024 Q4 150,286,895 $95,884,372 +$14,590,328 $0.64 101
2024 Q3 128,413,620 $176,562,559 -$7,293,208 $1.38 115
2024 Q2 133,365,913 $193,952,761 -$1,433,462 $1.45 114
2024 Q1 132,843,101 $296,874,901 +$3,769,415 $2.23 124
2023 Q4 131,309,565 $255,237,592 +$1,520,026 $1.94 116
2023 Q3 122,510,290 $180,096,177 +$237,767 $1.47 102
2023 Q2 122,233,983 $388,698,764 +$15,244,327 $3.18 98
2023 Q1 117,770,423 $277,898,040 +$604,828 $2.36 97
2022 Q4 116,732,928 $404,998,862 +$13,810,466 $3.47 94
2022 Q3 112,406,834 $823,966,061 +$50,675,691 $7.33 88
2022 Q2 105,615,240 $688,647,561 +$42,215,226 $6.52 72
2022 Q1 99,521,989 $502,714,970 +$55,442,935 $5.05 78
2021 Q4 85,540,866 $662,180,000 -$22,122,993 $7.74 76
2021 Q3 82,534,412 $1,221,509,324 +$39,832,274 $14.80 61
2021 Q2 79,701,853 $1,294,200,800 +$1,294,200,800 $16.24 52